---
title: "Audit of Lung Cancer Screening Practice in Chest Physicians: An Update"
nct_id: NCT02944903
overall_status: COMPLETED
sponsor: Assiut University
study_type: OBSERVATIONAL
primary_condition: Lung Cancer Screening
countries: Egypt
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02944903.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02944903"
ct_last_update_post_date: 2017-06-14
last_seen_at: "2026-05-12T07:01:35.785Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Audit of Lung Cancer Screening Practice in Chest Physicians: An Update

**Official Title:** Lung Cancer Screening Practice in Chest Physicians

**NCT ID:** [NCT02944903](https://clinicaltrials.gov/study/NCT02944903)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 75
- **Lead Sponsor:** Assiut University
- **Conditions:** Lung Cancer Screening
- **Start Date:** 2016-10
- **Completion Date:** 2017-06
- **CT.gov Last Update:** 2017-06-14

## Brief Summary

The investigators will conduct nationally representative survey in chest physicians in Egypt in 2016-2017. Self-administered questionnaire will be used to assess the physicians' knowledge of lung cancer screening guidelines, beliefs about the effectiveness of screening tests, and ordering of screening chest radiography, low-dose spiral computed tomography, or sputum cytology in the past 12 months.

## Detailed Description

Although current practice guidelines do not recommend screening asymptomatic patients for lung cancer, physicians may still order lung cancer screening tests. No recent national survey of health care professionals has focused on lung cancer screening

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Physicians practising in Egypt (Chest physicians, general practitioners, and general internists)

Exclusion Criteria:

* Other nationalities
* Other specialities
```

## Interventions

- **Audit** (OTHER) — Questionnair

## Primary Outcomes

- **Assessment of the use of guidelines of lung cancer screening** _(time frame: one year)_

## Secondary Outcomes

- **Self- administrated questionnaire** _(time frame: 6 months)_

## Locations (1)

- AssiutU, Asyut, Egypt

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.assiutu|asyut||egypt` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02944903.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02944903*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*